Amalus Therapeutics

Gent ·KBO/BCE: BE 0803.929.268

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	-207.3%	46.9%	better than 8% of 46 sector peers
Net result	€-342k	€-1k	better than 20% of 46 sector peers
Equity	€-332k	€108k	better than 5% of 46 sector peers
Gross operating margin	€111k	€28k	better than 81% of 42 sector peers
Total assets	€160k	€284k	better than 37% of 46 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€160k
Fixed assets	21/28	€5k
Financial fixed assets	28	€5k
Current assets	29/58	€155k
Amounts receivable within one year	40/41	€29k
Cash & bank	54/58	€123k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€160k
Equity	10/15	€-332k
Contributions / capital	10/11	€10k
Accumulated profits (losses)	14	€-342k
Amounts payable	17/49	€492k
Amounts payable after one year	17	€473k
Amounts payable within one year	42/48	€18k
Trade debts payable within one year	44	€4k
Income statement
Gross operating margin	9900	€111k
Operating result	9901	€-330k
Financial income	75	€95
Financial charges	65	€24k
Result before taxes	9903	€-354k
Income taxes	67/77	€-13k
Net result for the period	9904	€-342k
Result to be appropriated	9905	€-342k

NACE primary	Vervaardiging van farmaceutische grondstoffen(21100)
Legal form	Private limited company(610)
Incorporation	13-07-2023
Status	Active
Postal code	9052
First BS signal	10-03-2026
Latest BS signal	10-03-2026

Summary